Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

ValiRx (VAL) Share Price

Price 0.525p on 25-08-2025 at 04:45:13
Change 0.00p 0%
Buy 0.55p
Sell 0.50p
Last Trade: Buy 64,000.00 at 0.545p
Day's Volume: 0
Last Close: 0.525p
Open: 0.00p
ISIN: GB00BLH13C52
Day's Range 0.00p - 0.00p
52wk Range: 0.39p - 2.45p
Market Capitalisation: £1.97m
VWAP: 0.00p
Shares in Issue: 374.35m

ValiRx (VAL) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 64,000 0.545p Ordinary
15:09:29 - 22-Aug-25
Buy* 250,000 0.545p Ordinary
13:38:29 - 22-Aug-25
Buy* 183,486 0.545p Ordinary
11:38:19 - 22-Aug-25
Sell* 82,737 0.52p Ordinary
08:30:55 - 22-Aug-25
Buy* 1 0.53p Ordinary
08:09:06 - 22-Aug-25
Buy* 254 0.55p Ordinary
15:55:04 - 21-Aug-25
Buy* 56,000 0.545p Ordinary
11:35:04 - 21-Aug-25
Buy* 57,403 0.545p Ordinary
10:31:01 - 21-Aug-25
Buy* 3,659 0.5465p Ordinary
08:36:55 - 21-Aug-25
Buy* 25,000 0.545p Ordinary
16:16:31 - 20-Aug-25
See more ValiRx trades

ValiRx (VAL) Share Price History

Time period:
to
Date Open High Low Close Volume
22nd Aug 2025 (Fri) 0.525 0.525 0.525 0.525 602,658
21st Aug 2025 (Thu) 0.525 0.525 0.525 0.525 117,316
20th Aug 2025 (Wed) 0.525 0.525 0.525 0.525 25,000
19th Aug 2025 (Tue) 0.525 0.525 0.525 0.525 259,085
18th Aug 2025 (Mon) 0.525 0.525 0.525 0.525 160,078
15th Aug 2025 (Fri) 0.525 0.525 0.525 0.525 1,785
14th Aug 2025 (Thu) 0.525 0.525 0.525 0.525 937,119
13th Aug 2025 (Wed) 0.525 0.525 0.525 0.525 127,119
12th Aug 2025 (Tue) 0.525 0.525 0.525 0.525 361,270
11th Aug 2025 (Mon) 0.525 0.525 0.525 0.525 720,925
8th Aug 2025 (Fri) 0.60 0.60 0.525 0.525 7,487,401
7th Aug 2025 (Thu) 0.60 0.60 0.60 0.60 718,716
6th Aug 2025 (Wed) 0.60 0.60 0.60 0.60 3,893,466
5th Aug 2025 (Tue) 0.60 0.60 0.60 0.60 4,569,009
4th Aug 2025 (Mon) 0.60 0.60 0.60 0.60 1,699,212
1st Aug 2025 (Fri) 0.60 0.60 0.60 0.60 872,099
31st Jul 2025 (Thu) 0.60 0.60 0.60 0.60 226,405
30th Jul 2025 (Wed) 0.60 0.60 0.60 0.60 388,977
29th Jul 2025 (Tue) 0.60 0.60 0.60 0.60 2,087,865
28th Jul 2025 (Mon) 0.60 0.60 0.60 0.60 1,300,600
25th Jul 2025 (Fri) 0.60 0.60 0.60 0.60 2,143,950
See more ValiRx price history

ValiRx (VAL) Regulatory News

Date Source Headline
7th Aug 2025 10:51 am RNS ValiRx Awarded Grant from Open University
5th Aug 2025 9:53 am RNS Update on Evaluation Agreement with Stingray Bio
4th Aug 2025 7:00 am RNS Licensing Agreement with Dominion Biotech Ltd
29th Jul 2025 7:00 am RNS Collaboration Agreement with Voxcell BioInnovation
30th Jun 2025 3:48 pm RNS Result of AGM
20th Jun 2025 7:00 am RNS Ambrose Exercise Option on VAL401
9th Jun 2025 10:57 am RNS ValiRx Investor Webinar
6th Jun 2025 10:54 am RNS Holding(s) in Company
6th Jun 2025 7:00 am RNS Final Results & Notice of AGM
3rd Jun 2025 7:00 am RNS New Evaluation and Material Transfer Agreement
See more ValiRx regulatory news

ValiRx (VAL) Share News

ValiRx subsidiary Inaphaea agrees exclusive PredictRx licensing deal

4th Aug 2025 14:25

(Alliance News) - ValiRx PLC on Monday said subsidiary Inaphaea BioLabs has agreed an exclusive licensing deal with Dominion Biotech Ltd for Inaphaea's PredictRx platform. Read More

CORRECT: Stocks rise, UK data paints "gloomy" picture

20th Jun 2025 14:26

(Corrects the name of the AJ Bell analyst quoted.) Read More

LONDON MARKET MIDDAY: Stocks rise, UK data paints "gloomy" picture

20th Jun 2025 12:04

(Alliance News) - Stock prices in London were higher at midday on Friday, amid a slight lull in tensions over the Israel-Iran conflict after US President Donald Trump gave himself two weeks to decide whether to join Israel's strikes on Iran. Read More

ValiRx signs licence with Ambrose worth GBP16 million plus royalties

20th Jun 2025 10:41

(Alliance News) - ValiRx PLC shares surged on Friday as it said Ambrose Healthcare Ltd has exercised its option to licence its VAL401 asset for GBP16 million plus royalties. Read More

ValiRx subsidiary enters evaluation agreement with Omios Biologics

3rd Jun 2025 15:31

(Alliance News) - ValiRx PLC on Tuesday said subsidiary Cytolytix Ltd has entered an evaluation and material transfer agreement with California-based biotechnology firm Omios Biologics. Read More

See more ValiRx news
FTSE 100 Latest
Value9,321.40
Change12.20

Login to your account

Forgot Password?

Not Registered